ABC Family Arquivos Brasileiros de Cardiologia International Journal of Cardiovascular Sciences ABC Heart Failure & Cardiomyopathy ABC Imagem Cardiovascular
Português English
ABC Family
Português English
  • About
    • About ABC Family
    • Internal Regulation
    • Editorial Board
    • Brazilian Society of Cardiology (SBC)
  • Issues
  • SBC Guidelines
  • Content
    • Videos
    • Podcasts
    • News
  • About
    • About ABC Family
    • Internal Regulation
    • Editorial Board
    • Brazilian Society of Cardiology (SBC)
  • Issues
  • SBC Guidelines
  • Content
    • Videos
    • Podcasts
    • News

ABC Family

  • ABC Family
  • Arquivos Brasileiros de Cardiologia
  • International Journal of Cardiovascular Sciences
  • ABC Heart Failure & Cardiomyopathy
  • ABC Imagem Cardiovascular
Search in

No content found.

Journals
Ordering
Article types
Others

  1. Home
  2. Keyword: Genomics
Figure 1
ABCHF
Viewpoint

National Network of Cardiovascular Genomics: Implementing Genetic Diagnosis in Cardiology in the Brazilian Unified Health System

Tais Hanae Kasai-Brunswick et al. Dilza Balteiro Pereira de Campos Andressa Araújo Braga Raquel Tavares Boy da Silva … Eduardo Back Sternick Marisa da Silva Santos Helena Cramer Veiga Rey Adriana Bastos Carvalho

Genetic diagnosis is important

Hereditary cardiovascular diseases ( ) are the most frequent cause of sudden death in individuals under 35 years of age, and they remain an important cause of death up to 50 years of age. Although diagnosis of the proband, or index case, can be made clinically, it is only possible to screen family members who carry the gene variant that causes the disease by means of genetic diagnosis. This screening aims to institute measures that prevent sudden death and clinical surveillance in these family members, as well as reproductive counseling, when necessary. Several international guidelines recommend performing genetic diagnosis in different types of hereditary cardiovascular diseases. – In fact, hypertrophic cardiomyopathy guidelines consider genetic diagnosis a class I, level B-NR recommendation. Furthermore, genetic tests allow differential diagnosis with phenocopies of hypertrophic cardiomyopathy, such as Fabry disease, amyloidosis, PRKAG2 cardiomyopathy, among others. In pediatric patients, genetic testing may be even more important, as it allows the differential diagnosis with inborn errors of metabolism, for some of which there are therapeutic alternatives.

[…]

  • Exome Sequencing
  • Familial Hypertrophic Cardiomyopathy
  • Genomics
  • Heart Diseases
  • Sudden Death
Read Full Article
Creative Commons Attribution (CC BY) Creative Commons license
10/07/2023 DOI: 10.36660/abchf.20230011 Views 1
Figure 1
ABC
Viewpoint

The CRISPR/Cas9 System and the Possibility of Genomic Edition for Cardiology

Marcela Corso Arend et al. Jessica Olivaes Pereira Melissa Medeiros Markoski

Introduction

Cardiovascular diseases (CVD) and their associated pathologies are among the greatest causes of morbidity and mortality, entailing approximately 17.3 deaths a year. This class of pathology as a whole has a multi-factor etiology. Its possible prognoses lead to public health issues, with its incidence being related to behavioral, metabolic and genetic risk factors. In spite of the fact that the treatments established for the CVDs and their possible prognoses decrease the rhythm of progression of the illness, the need to develop therapeutic approaches able to reverse the pathology and its complications is growing.

The progresses in the fields of molecular and cellular biology have allowed the elucidation of molecular pathways and genetic causes involved in the establishment and progression of the CVDs, outlining a new viewpoint with regard to the prevention, treatment and possible outcomes of this pathological class. Recent discoveries, both experimental and those obtained by means of bioinformatics tools, regarding the molecular bases of cardiovascular dysfunctions, have been pointing to considerable therapeutic targets. However, most of these targets cannot be pharmacologically manipulated, which makes them potential candidates for genic therapy, such as the factors involved, for example, in angiogenesis, apoptosis and endothelial dysfunction. Within such context, gene manipulation may help suppress genetic factors connected to the incidence of the CVDs, as well as to mitigate the clinical complications caused by ischemic and occlusive events. Thus, the development and improvement of genome edition tools allow the creation of therapies focused in the genetic risk factors to cardiovascular damage and fundamental morphophysiological issues caused by the CVDs. In such context, the system formed by clustered regularly interspaced short palindromic repeats (CRISPR), and its CRISPR associated protein-9 (Cas9), stands out due to how easy it is to use it, its high specificity, easy in vitro and in vivo manipulation, in addition to the possibility of simultaneously editing multiple targets. Given the genomic complexity that intervenes in the CVDs, we shall indicate herein certain possibilities of applying the CRISPR/Cas9 tool in Cardiology.

[…]

  • Cardiovascular Diseases, mortality
  • Genomics
  • Molecular Biology
  • Morbidity
  • Prevention & Control
  • Risk Factors
Read Full Article
Creative Commons Attribution (CC BY) Creative Commons license
01/01/2017 DOI: 10.5935/abc.20160200 Views 2

How to cite this article

EndNote RIS

Electronic Document Format (Vancouver)

Kasai-Brunswick TH, Campos DBP, Braga AA, Silva RTB, Sternick EB, Santos MS, Rey HCV, et al. National Network of Cardiovascular Genomics: Implementing Genetic Diagnosis in Cardiology in the Brazilian Unified Health System. ABC Heart Fail Cardiomyop 2023;3(1):e20230011.

Electronic Document Format (ABNT)

Kasai-Brunswick, Tais Hanae; Campos, Dilza Balteiro Pereira de; Braga, Andressa Araújo; Silva, Raquel Tavares Boy da; Sternick, Eduardo Back; Santos, Marisa da Silva; Rey, Helena Cramer Veiga; Carvalho, Adriana Bastos. National Network of Cardiovascular Genomics: Implementing Genetic Diagnosis in Cardiology in the Brazilian Unified Health System. ABC Heart Fail Cardiomyop, v. 3, n. 1, e20230011, Jul. 2023.

Electronic Document Format (APA)

Kasai-Brunswick, T. H., Campos, D. B. P. , Braga, A. A., Silva, R. T. B. , Sternick, E. B., Santos, M. S., Rey, H. C. V., & Carvalho, A. B. (2023). National Network of Cardiovascular Genomics: Implementing Genetic Diagnosis in Cardiology in the Brazilian Unified Health System. ABC Heart Fail Cardiomyop, 3(1), e20230011.

Electronic Document Format (ISO)

Kasai-Brunswick, Tais Hanae and Campos, Dilza Balteiro Pereira de and Braga, Andressa Araújo and Silva, Raquel Tavares Boy da and Sternick, Eduardo Back and Santos, Marisa da Silva and Rey, Helena Cramer Veiga and Carvalho, Adriana Bastos. National Network of Cardiovascular Genomics: Implementing Genetic Diagnosis in Cardiology in the Brazilian Unified Health System. ABC Heart Fail Cardiomyop [online]. 2023, vol. 3, n. 1, [cited 2026-10-14], e20230011. Available from: <https://journals.cardiol.br/en/article/national-network-of-cardiovascular-genomics-implementing-genetic-diagnosis-in-cardiology-in-the-brazilian-unified-health-system/>

EndNote RIS

Electronic Document Format (Vancouver)

Arend MC, Pereira JO, Markoski MM. The CRISPR/Cas9 System and the Possibility of Genomic Edition for Cardiology. Arquivos Brasileiros de Cardiologia 2017;108(1):81-3.

Electronic Document Format (ABNT)

Arend, Marcela Corso; Pereira, Jessica Olivaes; Markoski, Melissa Medeiros. The CRISPR/Cas9 System and the Possibility of Genomic Edition for Cardiology. Arquivos Brasileiros de Cardiologia, v. 108, n. 1, p. 81-83, Dec. 2016.

Electronic Document Format (APA)

Arend, M. C., Pereira, J. O., & Markoski, M. M. (2017). The CRISPR/Cas9 System and the Possibility of Genomic Edition for Cardiology. Arquivos Brasileiros de Cardiologia, 108(1), 81-83.

Electronic Document Format (ISO)

Arend, Marcela Corso and Pereira, Jessica Olivaes and Markoski, Melissa Medeiros. The CRISPR/Cas9 System and the Possibility of Genomic Edition for Cardiology. Arquivos Brasileiros de Cardiologia [online]. 2017, vol. 108, n. 1, [cited 2026-10-14], pp. 81-83. Available from: <https://journals.cardiol.br/en/article/the-crispr-cas9-system-and-the-possibility-of-genomic-edition-for-cardiology/>. ISSN 0066-782X

  • About ABC Family
  • Internal Regulation
  • Editorial Board
  • Brazilian Society of Cardiology (SBC)

Issues

SBC Guidelines

  • Videos
  • Podcasts
  • News